Stemtech (STEK) Shares Outstanding (Weighted Average) (2012 - 2025)

Stemtech has disclosed Shares Outstanding (Weighted Average) across 14 years of filings, most recently posting $169.8 million for Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $169.8 million, up 43.07% year-over-year; the trailing twelve-month figure through Dec 2025 was $169.8 million (up 43.07% YoY), and the FY2025 annual result was $169.8 million, up 43.07% from the prior year.
• Shares Outstanding (Weighted Average) came in at $169.8 million for Q4 2025 at Stemtech, up from $150.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $169.8 million in Q4 2025 to a low of $19.1 million in Q3 2021.
• The 5-year median for Shares Outstanding (Weighted Average) is $83.5 million (2023), against an average of $82.6 million.
• Across the five-year window, Shares Outstanding (Weighted Average) soared 138.64% in 2022 and climbed 13.96% in 2024, its largest moves.
• Stemtech's Shares Outstanding (Weighted Average) stood at $35.3 million in 2021, then surged by 30.31% to $46.0 million in 2022, then surged by 81.4% to $83.5 million in 2023, then jumped by 42.2% to $118.7 million in 2024, then surged by 43.07% to $169.8 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $169.8 million (Q4 2025), $150.1 million (Q3 2025), and $140.2 million (Q2 2025), per Business Quant data.